Inhibiting the growth of ovarian cancer cells in vitro and in vivo by a small molecular inhibitor targeting La-RNA interactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibiting the growth of ovarian cancer cells in vitro and in vivo by a small molecular inhibitor targeting La-RNA interactions

Published:2023-02 Issue: Volume:940 Page:175471
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li Yueyan,Huang Xuan,Tang Jing^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. First-line chemotherapy in epithelial ovarian cancer;Bookman;Clin. Obstet. Gynecol.,2012

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018

3. RNA-binding proteins in neurodegeneration: mechanisms in aggregate;Conlon;Genes Dev.,2017

4. Screening approaches for targeting Ribonucleoprotein complexes: a new dimension for drug discovery;D'Agostino;SLAS discovery : advancing life sciences R & D,2019

5. First small-molecule inhibitors targeting the RNA-binding protein IGF2BP2/IMP2 for cancer therapy;Dahlem;ACS Chem. Biol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP